Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.16 | -6.27450980392 | 2.55 | 2.66 | 1.9907 | 804736 | 2.39377676 | CS |
| 4 | 0.43 | 21.9387755102 | 1.96 | 4.1 | 1.72 | 1550448 | 2.75850794 | CS |
| 12 | -0.67 | -21.8954248366 | 3.06 | 4.1 | 1.72 | 480165 | 2.76220375 | CS |
| 26 | -0.41 | -14.6428571429 | 2.8 | 4.1 | 1.72 | 221732 | 2.74806539 | CS |
| 52 | -4.603 | -65.822965823 | 6.993 | 10.6599 | 1.72 | 469690 | 6.07080158 | CS |
| 156 | -87.61 | -97.3444444444 | 90 | 112.2 | 1.72 | 282956 | 17.92389639 | CS |
| 260 | -162.61 | -98.5515151515 | 165 | 591.993 | 1.72 | 316303 | 99.21959268 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
